Breakthrough Prize in Life Sciences
The Breakthrough Prize in Life Sciences is an annual award recognizing outstanding achievements in the field of life sciences. Established in 2013, the prize aims to celebrate scientists who have made significant contributions to the understanding of living systems and the extension of human life.
History[edit | edit source]
The Breakthrough Prize in Life Sciences was founded by a group of prominent entrepreneurs and philanthropists, including Yuri Milner, Sergey Brin, Anne Wojcicki, Mark Zuckerberg, and Priscilla Chan. The prize was created to honor transformative advances in the life sciences, with a particular focus on research that extends human life.
Award[edit | edit source]
Each laureate of the Breakthrough Prize in Life Sciences receives a substantial monetary award, which is one of the largest in the scientific community. The prize is awarded based on the recommendations of a selection committee composed of previous laureates and other distinguished scientists.
Notable Laureates[edit | edit source]
Some of the notable recipients of the Breakthrough Prize in Life Sciences include:
- James P. Allison for his work on cancer immunotherapy.
- Karl Deisseroth for the development of optogenetics.
- Jennifer Doudna and Emmanuelle Charpentier for their pioneering work on the CRISPR-Cas9 gene-editing technology.
Selection Process[edit | edit source]
The selection process for the Breakthrough Prize in Life Sciences involves a rigorous evaluation of candidates' contributions to the field. Nominations are reviewed by a panel of experts, and the final selection is made by the prize's selection committee.
Impact[edit | edit source]
The Breakthrough Prize in Life Sciences has had a significant impact on the scientific community by providing substantial financial support and recognition to researchers. It has also helped to raise public awareness of the importance of life sciences research and its potential to improve human health.
Related Pages[edit | edit source]
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD